Free Access
| Issue |
Med Sci (Paris)
Volume 22, Number 1, Janvier 2006
|
|
|---|---|---|
| Page(s) | 84 - 86 | |
| Section | Chroniques bioéthiques | |
| DOI | https://doi.org/10.1051/medsci/200622184 | |
| Published online | 15 January 2006 | |
- Van Weely S, Leufkens HGM. Orphan diseases. In : Kaplan W, Laing R, eds. Priority medicines for Europe and the world : a public health approach to innovation. Geneva (Switzerland) : World Health Organization, 2004 : 95–100. [Google Scholar]
- Héron E. Les médicaments orphelins en Europe. Med Sci (Paris) 2005; 21 (n° spécial) : 66–8. [Google Scholar]
- Fischer A, Borensztein P, Roussel C. The European Rare Diseases Therapeutic Initiative. A public–private partnership is promoting research on new treatments for rare diseases. PloS Medicine 2005; 2 : e243. [Google Scholar]
- Premières rencontres multidisciplinaires sur la maladie de Fabry (24-25 juin 2005, Paris, France). Med Sci (Paris) 2005; 21 (n° spécial) : 1–84. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.